✦ LIBER ✦

Characteristics of frontotemporal dementia patients with a Progranulin mutation

✍ Scribed by Edward D. Huey; Jordan Grafman; Eric M. Wassermann; Pietro Pietrini; Michael C. Tierney; Bernardino Ghetti; Salvatore Spina; Matt Baker; Mike Hutton; Joshua W. Elder; Stephen L. Berger; Kyle A. Heflin; John Hardy; Parastoo Momeni

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 106 KB
Volume: 60
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.20969

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHMP2B mutations are not a cause of deme

CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia

✍ Patrizia Rizzu; Saskia E. van Mil; Burcu Anar; Sonia M. Rosso; Laura Donker Kaat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

SYMPTOMATOLOGICAL CHARACTERISTICS DISTIN

SYMPTOMATOLOGICAL CHARACTERISTICS DISTINGUISH BETWEEN FRONTOTEMPORAL DEMENTIA AND VASCULAR DEMENTIA WITH A DOMINANT FRONTAL LOBE SYNDROME

✍ MAGNUS SJÖGREN; ANDERS WALLIN; ÅKE EDMAN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Objective. Our hypothesis was that patients with vascular dementia and a dominating frontal lobe syndrome have a symptomatology that re¯ects a more widespread lesion compared with patients with frontotemporal dementia. Design. Patients with vascular dementia and a dominating frontal lobe syndrome (

Evidence of a founder effect in families

Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation

✍ Pickering-Brown, Stuart ;Baker, Matt ;Bird, Thomas ;Trojanowski, John ;Lee, Virg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

Moclobemide treatment of resistant depre

Moclobemide treatment of resistant depression in a patient with vascular dementia

✍ Yoram Barak; Hanna Suholitsky; Shlomo Noy 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

Patients suffering from dementia exhibit depressive symptoms in up to 86 per cent of cases. Syndromes meeting the criteria for major depression are more likely to respond to pharmacological therapy. Increased activity of M A 0 found in demented subjects make the treatment with MAO-inhibitors an obvi

Clinical and molecular studies of patien

Clinical and molecular studies of patients with characteristics of Opitz G/BBB syndrome shows a novel MID1 mutation

✍ Elena W.Y. Hsieh; Karin Vargervik; Anne M. Slavotinek 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Three years survival in patients with a

Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies

✍ Zuzana Walker; Ruth L. Allen; Sukhwinder Shergill; Eleanor Mullan; Cornelius L. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

The majority of information available on the prognosis of dementia with Lewy bodies (DLB) is based on retrospective data from autopsy series, which are subject to selection bias due to the speci®c reasons patients are referred for postmortem studies. The earlier studies comparing DLB patients with p